Efficacy of Fish Oil in Lupus Patients

Completed · Phase 4

Conditions studied: Systemic Lupus Erythematosus

In brief

The investigators hypothesize that low-dose dietary supplementation with omega-3 fish oil will improve disease activity and endothelial function in Systemic Lupus Erythematosus (SLE) patients.

Key facts

Study ID

NCT00828178

Run by

Michelle Petri M.D.,MPH

People needed

106

Starts

2009-02-01

Expected to finish

2011-02-01

Last updated by the study team

2016-11-18

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients with a clinical diagnosis of SLE are eligible.
• Patients must be 18 years of age or older and able to give informed consent.

You may not qualify if…

• SLE patients who are allergic to fish oil or any omega 3 product.
• Patients who are pregnant or are planning to become pregnant or are nursing.
• Omega-3 use within the previous 6 weeks of enrollment.
• Use of warfarin or heparin.
• Patients who have coronary artery disease.

Where it is running

• Lupus Center, Johns Hopkins University — Baltimore, Maryland, United States
• The Johns Hopkins Lupus Center — Baltimore, Maryland, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.